Nexstim has received three new NBS System orders
Helsinki, Finland: 22 December 2020 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) announces that it has received three new NBS system orders in December.
One purchase order came from a new neurosurgical customer in Spain. Two other orders came from existing Nexstim system users in Finland and in the United States. Those two orders are for NBS System upgrades meaning that an NBS System with the latest SmartFocus® nTMS features will replace the hospital’s older NBS system.
Nexstim NBS systems with SmartFocus® nTMS are mainly used for neurosurgical diagnostics to provide information on tumour’s or on other lesion’s location in relation to the essential functions and their connections in the patient’s brain. In addition, NBS Systems are used in research and in Europe the systems can also be used for depression and chronic, neuropathic pain therapy.
Further information on Nexstim’s website.